XAIRライブシグナル | Getagraph.comで利益を最大化

売る 110673 min ago

@ $2.12

発行日: 13 2月 2024 @ 05:17

リターン: -46.21%

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:49):

Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system...

Stats
本日の出来高	148 490
平均出来高	311 677
時価総額	52.33M
EPS	$0 ( 2024-02-12 )
次の収益日	( $-0.510 ) 2024-06-27
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.540
ATR14	$0.00500 (0.44%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-20	Lisi Steven A.	Buy	950 000	Stock Option (right to buy)
2024-03-20	Gaul Michael A.	Buy	350 000	Stock Option (right to buy)
2024-03-20	Lee Yoori	Buy	45 000	Stock Option (right to buy)
2024-03-20	Carey Robert	Buy	90 000	Stock Option (right to buy)
2024-03-20	Bentsur Ron	Buy	45 000	Stock Option (right to buy)

INSIDER POWER
97.65
Last 97 transactions
Buy: 8 447 739 \| Sell: 475 627

ボリューム相関

長: 0.02 (neutral)

短: 0.13 (neutral)

Signal:(36.994) Neutral

Beyond Air Inc 相関

10 最も正の相関
PAIC	0.905
TLGT	0.904
SPRT	0.883
SVOK	0.864
SVAC	0.863
RMRM	0.842
GOODM	0.821

10 最も負の相関
NETE	-0.879
MMAC	-0.839
AMRB	-0.835
RAVN	-0.833
BOCH	-0.816

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Beyond Air Inc 相関 - 通貨/商品

-0.64
( weak negative )

-0.14
( neutral )

0.00
( neutral )

0.11
( neutral )

-0.72
( moderate negative )

0.54
( weak )

Beyond Air Inc 財務諸表

Annual	2023
収益:	$0
総利益:	$-555 000 (0.00 %)
EPS:	$-1.860

FY	2023
収益:	$0
総利益:	$-555 000 (0.00 %)
EPS:	$-1.860

FY	2022
収益:	$0
総利益:	$-588 000 (0.00 %)
EPS:	$-1.680

FY	2021
収益:	$873 190
総利益:	$0.00 (0.00 %)
EPS:	$-1.270

Financial Reports:

No articles found.

Beyond Air Inc

Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.